Annual Report 2021
> A note from our Chair
• An eye-brain connection: Groundbreaking advancements for neurorehabilitation patients
• Shedding light on rare diseases
• Saving vision with gene therapies
• Biorepository: A new key to precision health
• Eye care at all ages: Bringing vision restoration to pediatric patients
• New center tackles rapidly growing myopia prevalence
• My second chance at sight: A patient’s hopeful journey after optic nerve stroke
• Global impact: Generous donors support global health efforts for cataract blindness
• A hopeful view on eyesight: Grateful patient celebrates Dr. Kuldev Singh’s 30th anniversary in 2022
• Fighting blindness across borders
• Stanford Belize Vision Clinic: Training the next generation of eye care providers
• Training for global care: Ophthalmology resident sets up two eye care programs in the Middle East
• Mentorship leads to new gene therapy discoveries
• 3D bioprinting to eliminate corneal blindness
• Big data to transform patient care
• Inventing a new outlook: Restoring sight with electronic photoreceptors and augmented reality glasses
• Eye care at the microscopic level
A note from our Chair
2021 marked a hopeful new chapter and my sixth year back at Stanford. We began this year still feeling the effects of the coronavirus (COVID-19) pandemic. Amid this pandemic, I have witnessed our department come together as we prioritized the safety of our patients, employees, and community. We continue to advance our devotion to clinical care, research, and education. While this year still included sanitization, masks and PPE, and physical distancing standards, it also included the rollout of COVID-19 vaccines. The unprecedented development and distribution of these vaccines was an important step mitigating against this pandemic and makes us optimistic for the future.
A few noteworthy department achievements over the past year include the Stanford Human Ocular Motor Lab’s neurorehabilitation work and our initiating the Stanford Human Perception Lab and the Vision Performance Center (pages 4-8); our pediatric team growing to provide the highest level of care in research and clinical settings (pages 12-15); strengthening our global health efforts in Belize and Africa with involvement from multiple department members (pages 20, 24, and 25); and accelerating research at the Mary M. and Sash A. Spencer Center for Vision Research at the Byers Eye Institute at Stanford thanks to the support of a number of generous philanthropic donors (pages 20-23).
As we look ahead to an ambitious strategic plan for 2022, I am again reminded of the privilege it is to lead our team at the Byers Eye Institute at Stanford. Every day I witness our team’s commitment to providing compassionate patient care, advancement of cutting edge basic and translational research, and training of the next generation of physicians and scientists in our field. I am confident we will carry these same practices forward, focused on our vision of a future without vision loss or blindness, in our community and around the world. It is my hope that this report gives you a glimpse into the innovative work we do.
With immense gratitude, I want to honor our donors, colleagues, staff, alumni, patients, and community for helping us build our distinguished Department of Ophthalmology.
Jeffrey L. Goldberg, MD, PhD
Blumenkranz Smead Professor and Chair of Ophthalmology
Byers Eye Institute at Stanford University